Literature DB >> 16279349

Tests for equivalence based on odds ratio for matched-pair design.

Jen-Pei Liu1, Hsin-Yi Fan, Mi-Chia Ma.   

Abstract

Currently, methods for evaluation of equivalence under a matched-pair design use either difference in proportions or relative risk as measures of risk association. However, these measures of association are only for cross-sectional studies or prospective investigations, such as clinical trials and they cannot be applied to retrospective research such as case-control studies. As a result, under a matched-pair design, we propose the use of the conditional odds ratio for assessment of equivalence in both prospective and retrospective research. We suggest the use of the asymptotic confidence interval of the conditional odds ratio for evaluation of equivalence. In addition, a score test based on the restricted maximum likelihood estimator (RMLE) is derived to test the hypothesis of equivalence under a matched-pair design. On the other hand, a sample size formula is also provided. A simulation study was conducted to empirically investigate the size and power of the proposed procedures. Simulation results show that the score test not only adequately controls the Type I error but it can also provide sufficient power. A numerical example illustrates the proposed methods.

Mesh:

Year:  2005        PMID: 16279349     DOI: 10.1080/10543400500265561

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  A Comparison of Testing Parameters and the Implementation of a Group Sequential Design for Equivalence Studies Using Paired-sample Analysis.

Authors:  Yunda Huang; Steven G Self
Journal:  Stat Biopharm Res       Date:  2012-01-01       Impact factor: 1.452

2.  A Five-Region Hypothesis Test for Exposure-Disease Associations.

Authors:  Han-Yi Shih; Wen-Chung Lee
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

3.  Rethinking statistical approaches to evaluating drug safety.

Authors:  Jen-pei Liu
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.